Skip to main content
. 2018 Aug 10;9(62):31985–31998. doi: 10.18632/oncotarget.25868

Figure 3. Creatine metabolism analysis after treatment with paclitaxel in uterine serous carcinoma cells.

Figure 3

Each cell line was treated with 15 nM paclitaxel or control vehicle for 24 h. Blue bars represent USPC-1 cells (control), red bars represent USPC-1 cells treated with paclitaxel, green bars represent PTX-1 cells (control) and yellow bars represent PTX-1 cells treated with paclitaxel. Values in the graphs represent the means ± SD of three independent experiments. *P < 0.05.